Aptargroup Inc(ATR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 29 at 5:30 AM ET (Korea 10/29 18:30)
Full metrics table
| Index | - | P/E | 22.98 | EPS (ttm) | 5.53 | Insider Own | 1.87% | Shs Outstand | 63.6M | Perf Week | 1.23% |
| Market Cap | 8.09B | Forward P/E | 20.59 | EPS next Y | 12.41% | Insider Trans | -3.31% | Shs Float | 62.4M | Perf Month | 3.15% |
| Enterprise Value | 9.35B | PEG | 3.34 | EPS next Q | 1.47 | Inst Own | 97.11% | Short Float | 3.32% | Perf Quarter | -5% |
| Income | 0.36B | P/S | 2.06 | EPS this Y | -4.27% | Inst Trans | 1.32% | Short Ratio | 4.52 | Perf Half Y | 3.47% |
| Sales | 3.93B | P/B | 3.08 | EPS next 5Y | 6.17% | ROA | 7.25% | Short Interest | 2.07M | Perf YTD | 4.27% |
| Book/sh | 41.33 | P/C | 40.99 | EPS past 3/5Y | 17.89% 12.87% | ROE | 13.61% | 52W High | -13.44% ($146.91) | Perf Year | -0.73% |
| Cash/sh | 3.1 | P/FCF | 26.05 | Sales past 3/5Y | 4.37% 5.22% | ROIC | 9.56% | 52W Low | 23.19% ($103.23) | Perf 3Y | 4.95% |
| Dividend Est. | $1.95 (1.53%) | EV/EBITDA | 11.77 | EPS Y/Y TTM | -5.14% | Gross Margin | 28.26% | Volatility(W/M) | 1.86% 1.75% | Perf 5Y | 0.94% |
| Dividend TTM | 1.92 | EV/Sales | 2.38 | Sales Y/Y TTM | 8.93% | Oper. Margin | 12.37% | ATR (14) | 2.28 | Perf 10Y | 74.16% |
| Dividend Ex-Date | 2026/7/30 | Quick Ratio | 1.1 | EPS Q/Q | -18.15% | Profit Margin | 9.22% | RSI (14) | 59.34 | Recom | 1.75 |
| Dividend Gr. 3/5Y | 6.38% 4.91% | Current Ratio | 1.61 | Sales Q/Q | 6.26% | SMA20 | 3.27% ($123.14) | Beta | 0.35 | Target Price | $162 |
| Payout | 31.11% | Debt/Eq | 0.54 | Earnings | 2026/10/29 | SMA50 | 1.07% ($125.82) | Rel Volume | 0.98 | Prev Close | $126.51 |
| Employees | 14000 | LT Debt/Eq | 0.44 | EPS/Sales Surpr. | 4.85% 1.69% | SMA200 | 0.24% ($126.87) | Avg Volume(3M) | 0.46M | Price | $127.17 |
| IPO | 1993/4/23 | Option/Short | Yes/Yes | Trades | 6423 | Volume | 449,282 | Change | 0.52% |
💊 A US-based company that supplies spray and delivery systems for pharmaceuticals, cosmetics, and food & beverages. The company provides drug delivery devices such as inhalers, nasal sprayers, and injectors, as well as cosmetic pumps and sprays and closure and dispensing solutions for food and beverages. It is known for the high margins of its drug delivery business and its consistent dividends.
Over the past 1 year, roughly in the middle
13% below its 1-year high.
Traded about as much as usual. That is 98% of its average volume.
Next earnings report: October 29
That is today.
ATR makes money exceptionally well
Of every $100 in sales, $12.37 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -4.3% this year.
Tap to view numbers
The price is about the industry average
For a company earning $100 a year, you would pay $2,298. Peers typically go for $2,952. Compared with its own 5-year average, it is 25% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Long-term returns are roughly flat
Bought 5 years ago, your return today would be +0.9%. The S&P 500 did +69% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 1.53% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 97.1%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #13 of 51 in the industry
Based on market cap of $8B.
AVTR#11 Avantor Inc $11B PER 33.6 
ALGN#12 Align Technology Inc $11B PER 26.6 ATR#13 Aptargroup Inc $8B PER 23.0 
BLCO#14 Bausch + Lomb Corp $7B PER - 
TFX#15 Teleflex Incorporated $6B PER - 
FAQ
What kind of company is ATR?
ATR belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of ATR?
The market cap of ATR is approximately $8.1B, ranking 1,040 within its sector.
Does ATR pay dividends?
ATR has a dividend yield of approximately 1.53%, with an annual dividend of $1.95.
What is the P/E ratio of ATR?
ATR has a P/E ratio of approximately 23.0x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ATR?
ATR has recorded a 52-week high of $146.91 and a low of $103.23.
